IntegenX - Ownership and Business Overview

Life ScienceCompany

IntegenX Ownership

Who owns IntegenX?

IntegenX is owned by Thermo Fisher Scientific. It was acquired on March 16, 2018.

IntegenX Business Overview

Where is IntegenX headquartered?

IntegenX is headquartered in Pleasanton, New Jersey.

What sector is IntegenX in?

IntegenX is a life science company.

When was IntegenX founded?

IntegenX was founded in 2003.

Life Science M&A Summary in 2018

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2018. The largest life science acquisition in 2018 was Shire - which was acquired by Takeda Pharmaceutical for $67.7B.

Join Mergr to view all 247 acquisitions of life science companies in 2018, including 45 acquisitions by private equity firms, and 202 by strategics.

IntegenX, Inc.

5720 Stoneridge Drive, Suite 300,
Pleasanton, New Jersey 94588
United States,
(925) 701-3400
www.integenx.com

IntegenX, Inc. is a developer of rapid human DNA identification technology. IntegenX technology platforms are the result of the integration of advanced fluidics, optics, and biochemistry capabilities to produce products for DNA-based human identity testing and forensics and biodefense applications. IntegenX, Inc. was established in 2003 and is based in Pleasanton, New Jersey.


 Subscribe to unlock this and 202,005
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.